Cargando…
Etoposide treatment in secondary hemophagocytic syndrome: impact on healthcare-associated infections and survival
BACKGROUND: Etoposide remains the cornerstone of symptomatic management of critically ill patients with secondary hemophagocytic syndrome (sHS). Risk of healthcare-associated infections (HAIs) in this setting with etoposide has never been assessed. We sought to evaluate the association between etopo...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616615/ https://www.ncbi.nlm.nih.gov/pubmed/36307626 http://dx.doi.org/10.1186/s13613-022-01075-9 |